Diagnostic Medical Systems S.A. (FRA:DMS1)

Market Cap	31.86M +43.4%
Revenue (ttm)	49.47M +9.2%
Net Income	-1.67M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	35.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.135
Previous Close	1.140
Day's Range	1.135 - 1.135
52-Week Range	1.040 - 1.590
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 28, 2026

About FRA:DMS1

Diagnostic Medical Systems S.A. designs, develops, manufactures, and sells medical imaging systems in France. The company offers ADAM, a software suite for imaging experts; R and F solutions, including Platinum Neo, Platinum Flex, and Optima; bone densitometers, including Stratos and Medix Series; MISTRAL, a manual chest and bone solution; and Camargue series which offers motorized radiographic systems to perform all types of bone and chest exams, including full spine and long leg exams. It also provides mobiles under the !M1, ONYX, Rafale/Rafa...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 140
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: DMS1

Financial Performance

In 2024, FRA:DMS1's revenue was 48.86 million, an increase of 10.74% compared to the previous year's 44.12 million. Losses were -2.88 million, -41.77% less than in 2023.